Articles tagged with Telomerase
A gene mutation that causes a rare premature aging disease could lead to the development of drugs that block rapid cell division in cancer. Researchers discovered a protein mutation that inhibits telomerase, allowing for the potential treatment of cancer and bone marrow failure.
Researchers at the Salk Institute have discovered a 'switch' in cells that can be turned on and off to control telomerase activity. This switch could help keep telomerase levels low, potentially slowing aging and regenerating vital organs.
Researchers at Arizona State University have published an atomic-level look at the telomerase enzyme that may hold secrets to the fountain of youth. Telomeres protect genetic data and are linked to aging and cancer.
Researchers at the University of Montreal have discovered a new role for non-coding RNA molecule TERRA in maintaining telomere length and protecting against cancer. By tracking telomerase molecules with TERRA, scientists found that this 'dark matter' plays a crucial role in regulating telomerase activity.
Researchers at The Wistar Institute have discovered a protein motif, TFLY, crucial to telomerase function, which can be disrupted to block enzyme activity. This finding offers new insights into developing drugs to inhibit telomerase and its potential role in cancer therapy.
Researchers found that statins can activate telomerase, slowing down senescent cells and potentially leading to healthy lifespan extension. The study suggests that statins could be used as an anti-aging therapy, mitigating age-related diseases like heart disease and cancer.
Researchers have developed a method to measure human genetic material's health in relation to age, using telomere length as an indicator. This technique could lead to the development of a 'genetic thermometer' to assess patient health.
Researchers found that individuals with untreated major depression have increased telomerase activity in immune cells, which may help fight back against disease progression. The study also suggests a potential protective role for telomerase in the hippocampus and reducing depressive symptoms with treatment.
Researchers at UT Southwestern Medical Center have found that alternative splicing may be a new approach for inhibiting telomerase, an enzyme driving uncontrolled division of cancer cells. By shifting the splicing, they demonstrated a potential method for turning off telomerase activity, which could lead to new cancer therapies.
Researchers from UCLA and UC Berkeley have solved the puzzle of the telomerase enzyme complex's three-dimensional structure, revealing its role in cancer and aging. The discovery opens up new approaches to fighting disease, particularly cancer, by allowing for targeted drug development.
Researchers successfully mapped telomerase, an enzyme that contributes to cellular rejuvenation and has a role in cancer development. The study's findings have implications for understanding the genetic correlation between cancer and telomere length.
Researchers discovered an identical gene mutation in the telomerase gene in all family members with malignant melanoma, leading to overactive telomerase and virtual immortality. The mutation was also found in non-inherited melanomas, suggesting a link between sun exposure and cancer development.
Scientists at UC Santa Cruz used a novel technique to study the structural and mechanical properties of telomeres, which could guide the development of new anti-cancer drugs. The research found that a small structural displacement causes the G-quadruplex structure to unfold, revealing its mechanical stability.
Researchers at CU-Boulder have discovered a novel target for anti-cancer drug development by targeting the telomerase enzyme at the ends of chromosomes. This approach may provide an effective solution to the complex problem of cancerous cells. By blocking the telomerase enzyme, the growth of cancerous cells can be prevented.
Telomerase is recruited to chromosome ends through interaction with protein TPP1. The researchers identified the exact region of TPP1 where telomerase binds and found that blocking this interaction prevents telomerase from reaching telomeres, causing cells to stop dividing.
Scientists at Max Planck Institute have discovered a molecular link between telomerase and the Wnt/β-signalling pathway, which regulates telomere length in stem cells and cancer cells. This regulation mechanism could lead to the development of new treatments for human tumours.
Researchers have discovered how a key protein assembles telomerase, an enzyme crucial for preventing DNA degradation and cancer cell proliferation. The study sheds new light on the telomerase enzyme's structure and function, which may help predict its behavior in humans and other organisms.
Researchers at CNIO successfully test first gene therapy to combat aging, extending mouse lifespan up to 24 percent and improving health. The therapy delivers a 'rejuvenating' effect using telomerase enzyme, repairing or delaying DNA damage.
Researchers discovered a two-step ritual in which RNA telomerase partners are prepared for interaction, revealing novel pharmaceutical approaches to cancer and diseases of aging. The study sheds light on the complex process of telomerase biogenesis and its connection to seemingly unrelated diseases.
Scientists at Salk Institute create worm model that relies on alternative lengthening of telomeres (ALT) pathway to maintain telomeres, a key strategy used by cancer cells. The study provides valuable tool to block ALT and induce senescence in tumor cells, with potential for developing new anti-cancer drugs.
A new study found that a brief, daily yoga meditation program reduced depressive symptoms and improved mental health in caregivers. The program also showed increased telomerase activity, slowing cellular aging.
A study employing mouse models and genomic analysis of human tumors identified the Smad4 gene as a driver in bone metastasis, while 14 other genes were found to be associated with human prostate cancer prognosis. Telomerase activation confers new strengths on tumors, enabling them to progress and acquire deadly characteristics.
Researchers found that inhibiting telomerase triggers alternative lengthening of telomeres (ALT) in cancer cells, leading to increased expression of PGC-1ß gene. Targeting PGC-1ß weakens mitochondria function and enhances anti-telomerase therapy.
Researchers have visualized telomerase molecules in living cells using advanced microscopy techniques, revealing that they cluster on specific telomeres and elongate them during cell division. This breakthrough provides new insights into the regulation of telomerase activity, a key factor in cancer development.
Researchers have identified a key target of DNA damage checkpoint enzymes that must be modified to enable stable telomere maintenance. This finding may hold crucial implications for preventing cancer and understanding human aging.
Researchers at Stanford University School of Medicine used undifferentiated induced pluripotent stem cells to study dyskeratosis congenita, a rare genetic disease. They found that the activity of telomerase, an enzyme critical to aging and cell renewal, is correlated with the severity of symptoms.
Researchers at UT Southwestern Medical Center have discovered that the telomerase enzyme repairs chromosomes in two distinct ways, depending on cell division and stress. This finding could lead to new cancer-fighting therapies by inhibiting this enzyme.
Researchers discover PinX1's role in preventing chromosome instability and cancer initiation. Low levels of PinX1 contribute to cancer development by activating telomerase, a process linked to human cancers with genetic alterations at chromosome 8p23.
Researchers found that meditation training is associated with greater telomerase activity, a key indicator of cellular health. Participants showed improvements in stress coping, mindfulness, and purpose, which were linked to higher telomerase levels.
Researchers at UCLA have created a three-dimensional structural model of the RNA core domain of the telomerase enzyme, which plays a critical role in cancer cell immortality. The new model provides insights into how telomerase functions and could lead to new approaches for treating diseases associated with telomerase activity.
Researchers at The Wistar Institute have discovered the dimeric nature of Cdc13, a protein crucial for maintaining telomere length. This discovery sheds light on how Cdc13 regulates telomerase activity, which can help prevent telomere shortening and support cancer treatment.
A team of Portuguese researchers has discovered that a specific Histone modification prevents DNA damage recognition machinery from arresting the cell cycle at telomere ends. This finding provides insights into the relationship between telomeres and cancer, as well as potential therapeutic interventions.
Research found that long-term physical activity activates telomerase and stabilizes telomeres, reducing telomere shortening in human leukocytes. This activation has an anti-aging effect on the cardiovascular system, potentially preventing age-related disease.
Researchers at Albert Einstein College of Medicine discovered a link between longevity and genes that maintain telomere length. The study found that individuals with long telomeres were more likely to have inherited genes that enabled effective telomerase production, potentially protecting against age-related diseases.
Researchers studied mice with a genetic deficiency that shortens their telomeres, similar to patients with dyskeratosis congenita. After 12-14 generations, the mice's telomeres regained normal lengths, suggesting an equilibration process that could protect against telomere erosion and disease symptoms.
Researchers at Stanford University School of Medicine have identified a novel connection between the telomerase molecule and the Wnt pathway in stem cell regulation. Overexpression of telomerase's TERT protein enhances Wnt-inducible genes, suggesting a potential new target for cancer therapies.
Human cytomegalovirus (HCMV) induces telomerase expression in both normal and malignant human cells, stimulating cell proliferation and immortalization. Additionally, a dietary supplement containing selenium, vitamin E, and beta-carotene reduces gastric cancer and overall mortality in individuals taking the supplements.
Researchers at Emory University School of Medicine discovered that immune cells from patients with rheumatoid arthritis have trouble turning on the enzyme that replenishes telomeres, leading to premature aging. This finding suggests that restoring defective telomerase could help 'reset' the immune system in rheumatoid arthritis.
Researchers at Stanford University School of Medicine have identified a protein called TCAB1, which is crucial for telomerase to repair the ends of chromosomes. This discovery may lead to new anti-cancer therapies by blocking the inappropriate expression of TCAB1 in human cancer cells.
The Baumann Lab discovered an important step in the maturation pathway of telomerase, an enzyme that replenishes chromosome ends with every cell division. This finding sheds light on human health and demonstrates that interfering with telomerase maturation can inactivate telomerase.
Researchers at the University of Rochester have found a previously unknown anti-cancer mechanism in small-bodied rodents with long lifespans. These cells are hypersensitive to surrounding tissue cues and can slow down cell division, potentially preventing tumor growth.
A pilot study found that comprehensive lifestyle changes increased telomerase levels by 29% and improved telomere maintenance capacity in immune system cells. This suggests a potential link between healthy habits and slower cellular aging.
Researchers at The Wistar Institute have deciphered the structure of telomerase, an enzyme playing a major role in nearly all human cancers. This achievement paves the way for new cancer treatments and anti-aging therapies by understanding how to deactivate telomerase.
Researchers have discovered that a protein called Est3 recognizes where to report to work through a specific 3-dimensional shape displayed on its surface. This finding has propelled forward studies of Est3's role in elongating chromosome ends and saving cells from premature growth arrest.
Researchers at UGA's Franklin College of Arts and Sciences have identified a mechanism that explains how telomerase enzymes are recruited to chromosome ends in cancer cells. The study highlights the potential for targeting telomerase as a means to stop cancers from spreading, providing new avenues for investigation into cancer growth.
Tumor cells can be made more sensitive to hyperthermia-enhanced radiation therapy by inhibiting telomerase, a protective enzyme. Researchers at Washington University School of Medicine found that moderately increasing heat activates telomerase in tumor cells.
Researchers at Stanford University School of Medicine have identified two new proteins that make up the telomerase complex, providing new targets for cancer treatments. The discovery could lead to the development of drugs that block telomerase and slow or stop cancer cell growth.
The Baumann lab has identified the long-sought telomerase RNA gene in a single-cell research model, providing a critical tool for studying telomerase in human cells. This breakthrough sheds light on the correlations between telomere shortening and various diseases, including cancer and coronary heart disease.
Dr. Elizabeth Blackburn, a UCSF biologist, has been awarded the L'Oreal-UNESCO prize for her pioneering work on telomere and telomerase research, which has led to a better understanding of cell aging and cancer. Her research aims to improve human well-being by developing interventions to prevent common diseases.
Researchers at The Wistar Institute have deciphered the three-dimensional structure of a telomerase domain essential for its activity. This finding may lead to the development of direct inhibitors of telomerase, a promising new target for anti-cancer therapies. The study's insights into normal aging are also warranted.
A Johns Hopkins team has discovered that shortening chromosome ends, called telomeres, can prevent cancer cells from growing by inducing a process known as senescence. This breakthrough could lead to new ways of preventing or treating cancer.
Scientists discovered that higher body mass, not lifespan, increases the risk of cancer due to telomerase expression. Rodents from various species showed a correlation between body size and telomerase activity, while human's don't express it in somatic cells, suggesting evolution prioritized cancer prevention over healing.
A team of Monash University scientists has identified two proteins, Smad3 and c-Myc, involved in stopping telomerase production. This discovery could lead to the development of anti-cancer agents that mimic these proteins.
Researchers found that suppressing telomerase, a key enzyme in cancer cell growth, can inhibit the spread of melanoma. By reducing glucose metabolism, cancer cells lose their ability to metastasize and regain lost pigmentation.
Researchers have successfully used a gene therapy approach to deliver telomerase, an enzyme that lengthens cell lifespan, without causing tumors in human patients. The technique allows for the growth of blood vessels in patients with vascular disease, offering new treatment options.
Researchers at Howard Hughes Medical Institute have identified a crucial protein domain in telomerase, an enzyme that contributes to cancer growth. The discovery provides new insights into the mechanism of cancer development and may lead to the development of targeted therapies.
Researchers found that mice with half the normal amount of telomerase can't maintain their stem cells' chromosome ends, leading to early demise. The study suggests that inherited disease may be caused by inherited telomere length, not the status of the telomerase gene.
A study found that telomerase activity in urine has high sensitivity and specificity for detecting bladder cancer, particularly in high-risk subgroups. The test is noninvasive, inexpensive, and easy to perform, making it a promising diagnostic tool for early cancer detection.
A University of Central Florida researcher has discovered a protein called MKRN1 that promotes the destruction of telomerase, an enzyme that enables rapid cell division. The study suggests that MKRN1 could be a critical component in preventing cancer cells from replicating uncontrollably.
Researchers have identified a novel protein, MKRN1, that regulates telomerase activity and maintains cellular telomere lengths. Increasing MKRN1 levels in cells promotes the degradation of telomerase enzyme hTERT, leading to decreased telomerase activity and shorter telomeres.